Inflammatory Disease and Lymphomagenesis Caused by Deletion of the Myc Antagonist Mnt in T Cells

REFERENCES

• Adhikary, S., and M. Eilers. 2005. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell. Biol. 6:635–645.
   PubMed Web of Science ®Google Scholar
• Blyth, K., A. Terry, M. O'Hara, E. W. Baxter, M. Campbell, M. Stewart, L. A. Donehower, D. E. Onions, J. C. Neil, and E. R. Cameron. 1995. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10:1717–1723.
   PubMed Web of Science ®Google Scholar
• Broussard-Diehl, C., S. R. Bauer, and R. H. Scheuermann. 1996. A role for c-myc in the regulation of thymocyte differentiation and possibly positive selection. J. Immunol. 156:3141–3150.
   PubMedGoogle Scholar
• Buckley, A. F., C. T. Kuo, and J. M. Leiden. 2001. Transcription factor LKLF is sufficient to program T cell quiescence via a c-myc-dependent pathway. Nat. Immunol. 2:698–704.
   PubMed Web of Science ®Google Scholar
• Cameron, E. R., M. Campbell, K. Blyth, S. A. Argyle, L. Keanie, J. C. Neil, and D. E. Onions. 1996. Apparent bypass of negative selection in CD8+ tumours in CD2-myc transgenic mice. Br. J. Cancer 73:13–17.
   PubMedGoogle Scholar
• Cameron, E. R., J. Morton, C. J. Johnston, J. Irvine, M. Bell, D. E. Onions, J. C. Neil, M. Campbell, and K. Blyth. 2000. Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene. Cell Death Differ. 7:80–88.
   PubMedGoogle Scholar
• Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916–2924.
   PubMed Web of Science ®Google Scholar
• Dong, C., and R. A. Flavell. 2000. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis Res. 2:179–188.
   PubMedGoogle Scholar
• Douglas, N. C., H. Jacobs, L. A. M. Bothwell, and A. C. Hayday. 2001. Defining the specific physiological requirements for c-Myc in T-cell development. Nat. Immunol. 2:307–315.
   PubMed Web of Science ®Google Scholar
• Elson, A., C. Deng, J. Campos-Torres, L. A. Donehower, and P. Leder. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11:181–190.
   PubMed Web of Science ®Google Scholar
• Fehling, H. J., and H. von Boehmer. 1997. Early αβ T cell development in the thymus of normal and genetically altered mice. Curr. Opin. Immunol. 9:263–275.
   PubMed Web of Science ®Google Scholar
• Felsher, D. W., and J. M. Bishop. 1999. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell 4:199–207.
   PubMed Web of Science ®Google Scholar
• Foley, K. P., G. A. McArthur, C. Queva, P. J. Hurlin, P. Soriano, and R. N. Eisenman. 1998. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17:774–785.
   PubMedGoogle Scholar
• Germain, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2:309–322.
   PubMed Web of Science ®Google Scholar
• Grumont, R., P. Lock, M. Mollinari, F. M. Shannon, A. Moore, and S. Gerondakis. 2004. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-κB-dependent c-myc. Immunity 21:19–30.
   PubMed Web of Science ®Google Scholar
• Hoffman, E. S., L. Passoni, T. Crompton, T. M. Leu, D. G. Schatz, A. Koff, M. J. Owen, and A. C. Hayday. 1996. Productive T cell receptor β-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo. Genes Dev. 10:948–962.
   PubMedGoogle Scholar
• Hueber, A.-O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and E. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305–1309.
   PubMed Web of Science ®Google Scholar
• Hurlin, P. J., C. Queva, and R. N. Eisenman. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11:44–58.
   PubMed Web of Science ®Google Scholar
• Hurlin, P. J., Z. Q. Zhou, K. Toyo-oka, S. Ota, W. L. Walker, S. Hirotsune, and A. Wynshaw-Boris. 2003. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J. 22:4584–4596.
   PubMedGoogle Scholar
• Imbert, V., J. F. Peyron, D. Farahi Far, B. Mari, P. Auberger, and B. Rossi. 1994. Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem. J. 297:163–173.
   PubMedGoogle Scholar
• Iritani, B. M., J. Delrow, C. Grandori, I. Gomez, M. Klacking, L. S. Carlos, and R. N. Eisenman. 2002. Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1. EMBO J. 21:4820–4830.
   PubMedGoogle Scholar
• Lo, J. F., H. Zhou, C. Fearns, R. A. Reisfeld, Y. Yang, and J. D. Lee. 2005. Tid1 is required for T cell transition from double-negative 3 to double-positive stages. J. Immunol. 174:6105–6112.
   PubMedGoogle Scholar
• Loo, L. W., J. Secombe, J. T. Little, L. S. Carlos, C. Yost, P. F. Cheng, E. M. Flynn, B. A. Edgar, and R. N. Eisenman. 2005. The transcriptional repressor dMnt is a regulator of growth in Drosophila melanogaster. Mol. Cell. Biol. 25:7078–7091.
   PubMedGoogle Scholar
• Lyons, A. B., and C. R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171:131–137.
   PubMed Web of Science ®Google Scholar
• Maclean, K. H., U. B. Keller, C. Rodriguez-Galindo, J. A. Nilsson, and J. L. Cleveland. 2003. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol. Cell. Biol. 23:7256–7270.
   PubMed Web of Science ®Google Scholar
• Mateyak, M. K., A. J. Obaya, and J. M. Sedivy. 1999. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 19:4672–4683.
   PubMed Web of Science ®Google Scholar
• Meroni, G., A. Reymond, M. Alcalay, G. Borsani, A. Tanigami, R. Tonlorenzi, C. L. Nigro, S. Messali, M. Zollo, D. H. Ledbetter, R. Brent, A. Ballabio, and R. Carrozzo. 1997. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J. 16:2892–2906.
   PubMed Web of Science ®Google Scholar
• Neurath, M. F., S. Finotto, and L. H. Glimcher. 2002. The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 8:567–573.
   PubMed Web of Science ®Google Scholar
• Nilsson, J. A., and J. L. Cleveland. 2003. Myc pathways provoking cell suicide and cancer. Oncogene 22:9007–9021.
   PubMed Web of Science ®Google Scholar
• Nilsson, J. A., K. H. Maclean, U. B. Keller, H. Pendeville, T. A. Baudino, and J. L. Cleveland. 2004. Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol. Cell. Biol. 24:1560–1569.
   PubMed Web of Science ®Google Scholar
• Ohashi, P. S. 2003. Negative selection and autoimmunity. Curr. Opin. Immunol. 15:668–676.
   PubMedGoogle Scholar
• Orian, A., B. van Steensel, J. Delrow, H. J. Bussemaker, L. Li, T. Sawado, E. Williams, L. W. Loo, S. M. Cowley, C. Yost, S. Pierce, B. A. Edgar, S. M. Parkhurst, and R. N. Eisenman. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev. 17:1101–1114.
   PubMed Web of Science ®Google Scholar
• O'Shea, J. J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37–45.
   PubMed Web of Science ®Google Scholar
• Oskarsson, T., and A. Trumpp. 2005. The Myc trilogy: lord of RNA polymerases. Nat. Cell Biol. 7:215–217.
   PubMed Web of Science ®Google Scholar
• Pai, S. Y., M. L. Truitt, C. N. Ting, J. M. Leiden, L. H. Glimcher, and I. C. Ho. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863–875.
   PubMed Web of Science ®Google Scholar
• Pelengaris, S., M. Khan, and G. Evan. 2002. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2:764–776.
   PubMed Web of Science ®Google Scholar
• Peyrefitte, S., D. Kahn, and M. Haenlin. 2001. New members of the Drosophila Myc transcription factor subfamily revealed by a genome-wide examination for basic helix-loop-helix genes. Mech. Dev. 104:99–104.
   PubMedGoogle Scholar
• Poortinga, G., K. M. Hannan, H. Snelling, C. R. Walkley, A. Jenkins, K. Sharkey, M. Wall, Y. Brandenburger, M. Palatsides, R. B. Pearson, G. A. McArthur, and R. D. Hannan. 2004. MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO J. 23:3325–3335.
   PubMedGoogle Scholar
• Queva, C., G. A. McArthur, B. M. Iritani, and R. N. Eisenman. 2001. Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. Mol. Cell. Biol. 21:703–712.
   PubMedGoogle Scholar
• Rudolph, B., A. O. Hueber, and G. I. Evan. 2000. Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro. Oncogene 19:1891–1900.
   PubMedGoogle Scholar
• Rudolph, B., A. O. Hueber, and G. I. Evan. 2001. Expression of Mad 1 in T cells leads to reduced thymic cellularity and impaired mitogen-induced proliferation. Oncogene 20:1164–1175.
   PubMedGoogle Scholar
• Schreiber-Agus, N., Y. Meng, T. Hoang, H. Hou, Jr., K. Chen, R. Greenberg, C. Cordon-Cardo, H. W. Lee, and R. A. DePinho. 1998. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393:483–487.
   PubMed Web of Science ®Google Scholar
• Shi, Y., J. M. Glynn, L. J. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212–214.
   PubMed Web of Science ®Google Scholar
• Skapenko, A., J. Leipe, P. E. Lipsky, and H. Schulze-Koops. 2005. The role of the T cell in autoimmune inflammation. Arthritis Res. Ther. 7:S4–S14.
   PubMed Web of Science ®Google Scholar
• Smith, D. P., M. L. Bath, A. W. Harris, and S. Cory. 2005. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumors in transgenic mice with broad haemopoietic expression of MYC. Oncogene 24:3544–3545.
   PubMedGoogle Scholar
• Stewart, M., E. Cameron, M. Campbell, R. McFarlane, S. Toth, K. Lang, D. Onions, and J. C. Neil. 1993. Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region. Int. J. Cancer 53:1023–1030.
   PubMed Web of Science ®Google Scholar
• Takahama, Y., K. Ohishi, Y. Tokoro, T. Sugawara, Y. Yoshimura, M. Okabe, T. Kinoshita, and J. Takeda. 1998. Functional competence of T cells in the absence of glycosylphosphatidylinositol-anchored proteins caused by T cell-specific disruption of the Pig-a gene. Eur. J. Immunol. 28:2159–2166.
   PubMed Web of Science ®Google Scholar
• Toyo-oka, K., S. Hirotsune, M. J. Gambello, Z. Q. Zhou, L. Olson, M. G. Rosenfeld, R. Eisenman, P. Hurlin, and A. Wynshaw-Boris. 2004. Loss of Max-interacting protein Mnt in mice results in decreased viability, defective embryonic growth and craniofacial defects: relevance to Miller-Dieker syndrome. Hum. Mol. Genet. 13:1057–1067.
   PubMed Web of Science ®Google Scholar
• Trumpp, A., Y. Refaeli, T. Oskarsson, S. Gasser, M. Murphy, G. R. Martin, and J. M. Bishop. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414:768–773.
   PubMed Web of Science ®Google Scholar
• van Ewijk, W. 1991. T-cell differentiation is influenced by thymic microenvironment. Annu. Rev. Immunol. 9:591–615.
   PubMed Web of Science ®Google Scholar
• Walker, W., Z.-Q. Zhou, S. Ota, A. Wynshaw-Boris, and P. J. Hurlin. 2005. Mnt-Max to Myc-Max complex switching regulates cell cycle entry. J. Cell Biol. 10:1083–1091.
   Google Scholar
• Wilson, A., M. J. Murphy, T. Oskarsson, K. Kaloulis, M. D. Bettess, G. M. Oser, A. C. Pasche, C. Knabenhans, H. R. Macdonald, and A. Trumpp. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 18:2747–2763.
   PubMed Web of Science ®Google Scholar
• Yang, W., J. Shen, M. Wu, M. Arsura, M. FitzGerald, Z. Suldan, D. W. Kim, C. S. Hofmann, S. Pianetti, R. Romieu-Mourez, L. P. Freedman, and G. E. Sonenshein. 2001. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688–1702.
   PubMed Web of Science ®Google Scholar
• Zhang, L., V. Camerini, T. P. Bender, and K. S. Ravichandran. 2002. A nonredundant role for the adapter protein Shc in thymic T cell development. Nat. Immunol. 3:749–755.
   PubMedGoogle Scholar
• Zhou, Z.-Q., and P. J. Hurlin. 2001. The interplay between Mad and Myc in proliferation and differentiation. Trends Cell Biol. 11:S10.
   PubMedGoogle Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar